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E-mail: v.baehr@imd-berlin.deI would like to comment on the letter from Dessau et al.:
“Lymphocyte transformation test for diagnosis of Lyme
borreliosis is currently not documented to be clinically useful”
[1]. I wish to thank Dessau and colleagues for their interest in
our study and am very pleased that they conﬁrm that the
lymphocyte transformation test (LTT) shows a high speciﬁcity
in seronegative cases [1]. Especially in such cases, the validity of
the LTT is often controversially reported. As expected, the
speciﬁcity was lower in seropositive samples than in seroneg-
ative cases, most likely due to the persistence of few, prolif-
erating memory cells in the blood. Since antibody
determinations often do not lead to secure diagnostic results,
the speciﬁcity of 91.6% of the LTT in seropositive patients may
be considered as acceptable. In many cases with positive anti-
body results, the suspicion of an active borreliosis can be
eliminated by a negative LTT, although a false-positive rate of
8.4% must be considered in the assessment. Our publication
points to the fact that clinical results are decisive for diagnosis,
whereas laboratory diagnostics, including the LTT, may provide
additional indications only.
The diagnosis of borreliosis in 94 patients was based exclu-
sively on clinical results, taking serology and medical history into
account. In our manuscript, the clinical manifestations of 94 pa-
tients are described in the fourth paragraph, in the section
“Subjects and Patients.” It is well known that borreliosis cannotMicrobiol Infect 2015; 21: e22
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p://dx.doi.org/10.1016/j.cmi.2014.10.001be diagnosed unequivocally. The aim of the present study was to
examine the correlation between LTT result and disease activity,
thus, the combination of medical history and clinical and sero-
logical ﬁndings were used for diagnosis of borreliosis.
I do not agree with the statement of Dessau and colleagues
that our results do not conﬁrm the inhibitory effects of anti-
biotic treatment on T cell reactivity [1]. Although the study
was not speciﬁcally designed to address the clinical outcome of
the patients following antibiotic therapy, the 92.1% and 53.3%
decreases in T cell reactivity in patients with early and late
phase manifestations, respectively, show an inhibitory effect of
antibiotic treatment on the LTT result. This conﬁrms our
ﬁndings that T cell reactivity was Borrelia-speciﬁc in most cases.
In addition, our results are supported by recently published
data [2,3].
In contrast to the opinion of the colleagueswho attest a clinical
relevance of LTT in the future only, our results indicate that LTT
may already provide a useful diagnostic tool for the detection of
borreliosis in difﬁcult cases. The prerequisite for its application is
an adequate speciﬁcity, and the interpretation of LTT results in
the context of medical history, clinical ﬁndings, and serological
procedures. However, we also emphasize the requirement for
standardisation among testing laboratories in the near future.Transparency declarationThe author has no conﬂict of interested related to the present
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